HK1041290B - 新型腫瘤抗原蛋白sart-3及其腫瘤抗原肽 - Google Patents

新型腫瘤抗原蛋白sart-3及其腫瘤抗原肽

Info

Publication number
HK1041290B
HK1041290B HK02102831.7A HK02102831A HK1041290B HK 1041290 B HK1041290 B HK 1041290B HK 02102831 A HK02102831 A HK 02102831A HK 1041290 B HK1041290 B HK 1041290B
Authority
HK
Hong Kong
Prior art keywords
tumor antigen
novel
antigen protein
peptide
protein sart
Prior art date
Application number
HK02102831.7A
Other languages
English (en)
Other versions
HK1041290A1 (en
Inventor
伊東恭悟
中尾真修
Original Assignee
伊東恭悟
大日本住友制藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 伊東恭悟, 大日本住友制藥株式會社 filed Critical 伊東恭悟
Publication of HK1041290A1 publication Critical patent/HK1041290A1/xx
Publication of HK1041290B publication Critical patent/HK1041290B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK02102831.7A 1998-08-28 2002-04-15 新型腫瘤抗原蛋白sart-3及其腫瘤抗原肽 HK1041290B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24266098 1998-08-28
PCT/JP1999/004622 WO2000012701A1 (fr) 1998-08-28 1999-08-27 Nouvelle proteine d'antigene tumoral sart-3 et peptide d'antigene tumoral de celle-ci

Publications (2)

Publication Number Publication Date
HK1041290A1 HK1041290A1 (en) 2002-07-05
HK1041290B true HK1041290B (zh) 2007-03-09

Family

ID=17092354

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102831.7A HK1041290B (zh) 1998-08-28 2002-04-15 新型腫瘤抗原蛋白sart-3及其腫瘤抗原肽

Country Status (14)

Country Link
US (4) US7541428B2 (zh)
EP (1) EP1116791B1 (zh)
JP (2) JP4436977B2 (zh)
KR (1) KR100660367B1 (zh)
CN (1) CN1264980C (zh)
AT (1) ATE412747T1 (zh)
AU (1) AU762516B2 (zh)
CA (1) CA2340888C (zh)
DE (1) DE69939833D1 (zh)
ES (1) ES2316191T3 (zh)
HK (1) HK1041290B (zh)
ID (1) ID29405A (zh)
NZ (1) NZ510154A (zh)
WO (1) WO2000012701A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1116791B1 (en) * 1998-08-28 2008-10-29 Kyogo Itoh Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
JP2002365286A (ja) * 2000-11-13 2002-12-18 Kyogo Ito 細胞性免疫検出法およびその医薬への応用
WO2003025569A1 (fr) * 2001-09-18 2003-03-27 Kyogo Itoh Procede de detection de l'immunite cellulaire et son application sur des medicaments
CA2534461A1 (en) * 2003-08-05 2005-02-10 Green Peptide Co., Ltd An agent for preventing and/or treating hematologic malignancies
CA2538300A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent
JP5114403B2 (ja) * 2006-07-11 2013-01-09 株式会社グリーンペプタイド Ｈｌａ−ａ３スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なｓａｒｔ３由来ペプチド
KR101512885B1 (ko) 2007-09-18 2015-04-16 가부시키가이샤 그린 펩티드 Ｃｔｌ 유도제 조성물
ES2620277T3 (es) 2010-07-07 2017-06-28 Green Peptide Co., Ltd. Vacuna peptídica contra el cáncer
BR112015021162A2 (pt) 2013-03-08 2017-10-10 Taiho Pharmaceutical Co Ltd peptídeo tendo 5 epítopos de ctl ligados
JP6211093B2 (ja) * 2013-10-21 2017-10-11 大鵬薬品工業株式会社 新規ｃｔｌエピトープ４連結ペプチド
US20210236613A1 (en) 2018-06-29 2021-08-05 Taiho Pharmaceutical Co., Ltd. Antitumor agent and evaluation method thereof
KR20220120627A (ko) 2019-12-26 2022-08-30 다이호야쿠힌고교 가부시키가이샤 수술 후 보조 요법제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ271774A (en) * 1993-08-06 1998-02-26 Cytel Corp Immunogenic peptides from the c-terminus of the mage-1 (melanoma) antigen
NZ333203A (en) 1996-06-07 2000-07-28 Kyogo Itoh Tumour antigen proteins, genes thereof, and tumour antigen peptides
EP1116791B1 (en) * 1998-08-28 2008-10-29 Kyogo Itoh Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1769088A2 (en) 2004-06-30 2007-04-04 Whitehead Institute For Biomedical Research Novel methods for high-throughput genome-wide location analysis

Also Published As

Publication number Publication date
AU762516B2 (en) 2003-06-26
US20090297544A1 (en) 2009-12-03
AU5444199A (en) 2000-03-21
US8563684B2 (en) 2013-10-22
US20110243974A1 (en) 2011-10-06
EP1116791B1 (en) 2008-10-29
ID29405A (id) 2001-08-30
CA2340888A1 (en) 2000-03-09
US20120123090A1 (en) 2012-05-17
EP1116791A4 (en) 2002-01-09
US8097697B2 (en) 2012-01-17
JP4904384B2 (ja) 2012-03-28
CN1264980C (zh) 2006-07-19
WO2000012701A1 (fr) 2000-03-09
NZ510154A (en) 2002-11-26
CA2340888C (en) 2008-08-05
US7541428B2 (en) 2009-06-02
JP4436977B2 (ja) 2010-03-24
KR100660367B1 (ko) 2006-12-21
US20060140968A1 (en) 2006-06-29
ATE412747T1 (de) 2008-11-15
JP2010029194A (ja) 2010-02-12
KR20010074895A (ko) 2001-08-09
HK1041290A1 (en) 2002-07-05
US7968676B2 (en) 2011-06-28
EP1116791A1 (en) 2001-07-18
DE69939833D1 (de) 2008-12-11
ES2316191T3 (es) 2009-04-01
CN1324404A (zh) 2001-11-28

Similar Documents

Publication Publication Date Title
EP1090924B8 (en) Tumor antigen peptides originating in cyclophilin b
WO1998037093A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
AU3209097A (en) Neuroactive peptides
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
WO1999047674A3 (en) Compounds and methods for therapy and diagnosis of lung cancer
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1999038973A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
PL354348A1 (en) Compounds and methods for therapy and diagnosis of lung cancer
HK1041290A1 (en) Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
AU9572098A (en) Novel human cancer antigen ny eso-1/cag-3 and gene encoding same
EP1055684A4 (en) TUMORANTIGENS IN THE FORM OF PEPTIDE DERIVATIVES
EP0911397A4 (en) TUMORANTANT PROTEINS, THEIR GENES, AND TUMORANTANT PEPTIDES
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
ZA971403B (en) Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof.
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
EP0885959A3 (en) Human Wnt-5b protein
EP1103561A4 (en) HLA-A2 LIMITING TUMOR ANTIGEN PEPTIDE FROM SART-1
AU714548C (en) Tumor antigen proteins, genes therefor, and tumor antigen peptides
Guan Development of liposomal antigen delivery system for synthetic muc1 peptides
EP2003201A3 (en) Compounds and methods for therapy and diagnosis of lung cancer
EP1186662A3 (en) Prion binding proteins and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100827